Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1996 Mar;49(3):264–267. doi: 10.1136/jcp.49.3.264

Lymphocyte infiltration in oesophageal carcinoma: lack of correlation with MHC antigens, ICAM-1, and tumour stage and grade.

J C Rockett 1, S J Darnton 1, J Crocker 1, H R Matthews 1, A G Morris 1
PMCID: PMC500414  PMID: 8675745

Abstract

Infiltration by T lymphocytes into oesophageal carcinomas was assessed immunohistochemically, total T lymphocyte numbers by staining for CD3 and activated T lymphocytes by staining for CD25. Five squamous carcinomas and seven adenocarcinomas, resected without neoadjuvant treatment, were studied. Computer aided quantitation showed that total numbers of tumour infiltrating CD3 positive cells were highly variable (range 48-1673 cells/mm2). They were located largely in the stromal (87.9-99.2%) rather than intratumoral regions. Up to 84% of tumour infiltrating T lymphocytes were CD25 positive, although the median figure was 33%. There was no correlation between T lymphocyte infiltration or activation and expression of class I and II histocompatibility antigens, intercellular adhesion molecule-1, tumour stage or grade. These results imply that the local inflammatory response in oesophageal carcinomas is deregulated, which may be a factor contributing to the aggressive nature of the tumours.

Full text

PDF
264

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Garrido F., Cabrera T., Concha A., Glew S., Ruiz-Cabello F., Stern P. L. Natural history of HLA expression during tumour development. Immunol Today. 1993 Oct;14(10):491–499. doi: 10.1016/0167-5699(93)90264-L. [DOI] [PubMed] [Google Scholar]
  2. Glew S. S., Duggan-Keen M., Cabrera T., Stern P. L. HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res. 1992 Jul 15;52(14):4009–4016. [PubMed] [Google Scholar]
  3. Johnson J. P. The role of ICAM-1 in tumor development. Chem Immunol. 1991;50:143–163. [PubMed] [Google Scholar]
  4. Nonomura A., Mizukami Y., Shimizu J., Hayashi Y., Murakami S., Watanabe Y., Kamimura R., Takashima T. Simultaneous detection of intercellular adhesion molecule-1 (CD54) and carcinoembryonic antigen in lung adenocarcinoma. Mod Pathol. 1994 Feb;7(2):155–160. [PubMed] [Google Scholar]
  5. Nouri A. M., Hussain R. F., Oliver R. T., Handy A. M., Bartkova I., Bodmer J. G. Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens. Eur J Cancer. 1993;29A(13):1895–1899. doi: 10.1016/0959-8049(93)90545-q. [DOI] [PubMed] [Google Scholar]
  6. Rockett J. C., Darnton S. J., Crocker J., Matthews H. R., Morris A. G. Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma. J Clin Pathol. 1995 Jun;48(6):539–544. doi: 10.1136/jcp.48.6.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Vesalainen S., Lipponen P., Talja M., Syrjänen K. Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer. 1994;30A(12):1797–1803. doi: 10.1016/0959-8049(94)e0159-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES